Get started
Author

David Burt

Observed name: D. Burt
ORCID: 0000-0001-8525-3258
Observed ORCID: 0000-0001-8525-3258
OpenAlex ID: A5049281279
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
2021 · David Gordon, Edward T Hellriegel, et al. · Clinical Pharmacology Advances and Applications · 28
PDF
Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis
2023 · David Gordon, Alan Kivitz, et al. · ACR Open Rheumatology · 17
PDF
Statistical Assessment of QT/QTc Prolongation Based on Maximum of Correlated Normal Random Variables
2008 · Bin Cheng, Shein-Chung Chow, et al. · Journal of Biopharmaceutical Statistics · 17
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
2023 · Paul Changelian, Canxin Xu, et al. · JID Innovations · 9
Characterization of the dual ITK/JAK3 small molecule covalent inhibitor ATI-2138
2024 · Aparna Kaul, Heidi Hope, et al. · Journal of Pharmacology and Experimental Therapeutics · 6
Bandwidth Selection Concerns for Jump Point Discontinuity Preservation in the Regression Setting Using M-smoothers and the Extension to Hypothesis Testing
2000 · David Burt · VTechWorks (Virginia Tech) · 3
PDF
Sat0143 a Phase 1 Study in Healthy Volunteers Exploring the Safety, Pharmacokinetics and Pharmacodynamics of Ati-450: a Novel Oral Mk2 Inhibitor
2020 · J. Schnyder, J. Monahan, et al. · Annals of the Rheumatic Diseases · 2
Authors' Response to “Comment on: Cheng, Chow, Burt, and Cosmatos (2008). Statistical Assessment of QT/QTc Prolongation Based on Maximum of Correlated Normal Random Variables”
2010 · Bin Cheng, Shein-Chung Chow, et al. · Journal of Biopharmaceutical Statistics
Works count: 8
Citation count: 82
H-index: 5
I10-index: 3
Year
Topic
Type